Finance

Lists
Why is BIM up 3,48%?
Dive Deeper
BIM:EPA
BioMerieux SA
83,20 €
+3,48%
(+2,80) 1D
9 հոկ, 17:36:27 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIM...
Open
82,00 €
High
83,40 €
Low
82,00 €
Mkt. cap
9,50 մլրդ
Avg. vol.
165,79 հզր
Volume
201,38 հզր
P/E ratio
21,33
52-wk high
116,10 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 մլն
No. of employees
15 հզր
Open
82,00 €
High
83,40 €
Low
82,00 €
Mkt. cap
9,50 մլրդ
Avg. vol.
165,79 հզր
Volume
201,38 հզր
P/E ratio
21,33
52-wk high
116,10 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 մլն
No. of employees
15 հզր
News stories
From web sources and news partners
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14,9 հզր
Founded1963
HeadquartersMarcy-l'Étoile, Ռոն Ալպեր, Ֆրանսիա
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,01 մլրդ
1,01 մլրդ
982,30 մլն
982,30 մլն
Cost of goods sold
442,05 մլն
442,05 մլն
433,20 մլն
433,20 մլն
Cost of revenue
442,05 մլն
442,05 մլն
433,20 մլն
433,20 մլն
Research and development expenses
129,00 մլն
129,00 մլն
128,70 մլն
128,70 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
271,20 մլն
271,20 մլն
272,15 մլն
272,15 մլն
Operating expense
400,65 մլն
400,65 մլն
399,50 մլն
399,50 մլն
Total operating expenses
842,70 մլն
842,70 մլն
832,70 մլն
832,70 մլն
Operating income
170,30 մլն
170,30 մլն
149,60 մլն
149,60 մլն
Other non operating income
-
-
200,00 հզր
200,00 հզր
EBT including unusual items
156,25 մլն
156,25 մլն
147,30 մլն
147,30 մլն
EBT excluding unusual items
171,85 մլն
171,85 մլն
148,60 մլն
148,60 մլն
Income tax expense
38,10 մլն
38,10 մլն
34,40 մլն
34,40 մլն
Effective tax rate
24,38%
24,38%
23,35%
23,35%
Other operating expenses
-7,30 մլն
-7,30 մլն
-8,45 մլն
-8,45 մլն
Net income
118,25 մլն
118,25 մլն
113,05 մլն
113,05 մլն
Net profit margin
11,67%
11,67%
11,51%
11,51%
Earnings per share
-
-
-
-
Interest and investment income
3,30 մլն
3,30 մլն
3,95 մլն
3,95 մլն
Interest expense
-4,20 մլն
-4,20 մլն
-3,85 մլն
-3,85 մլն
Net interest expenses
-900,00 հզր
-900,00 հզր
100,00 հզր
100,00 հզր
Depreciation and amortization charges
7,75 մլն
7,75 մլն
-
-
EBITDA
327,00 մլն
327,00 մլն
207,75 մլն
207,75 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps